User profiles for W. S. Kim

Won Seog kim

- Verified email at skku.edu - Cited by 79962

Woo-Sik Kim

- Verified email at khu.ac.kr - Cited by 7587

Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states

YS Lee, WS Kim, KH Kim, MJ Yoon, HJ Cho, Y Shen… - Diabetes, 2006 - Am Diabetes Assoc
Berberine has been shown to have antidiabetic properties, although its mode of action is not
known. Here, we have investigated the metabolic effects of berberine in two animal models …

[HTML][HTML] Recent progress on magnetic iron oxide nanoparticles: synthesis, surface functional strategies and biomedical applications

…, Z Wu, T Yu, C Jiang, WS Kim - Science and technology of …, 2015 - iopscience.iop.org
This review focuses on the recent development and various strategies in the preparation,
microstructure, and magnetic properties of bare and surface functionalized iron oxide …

The wound-healing and antioxidant effects of adipose-derived stem cells

WS Kim, BS Park, JH Sung - Expert opinion on biological therapy, 2009 - Taylor & Francis
Background: The aim of tissue engineering is to repair and regenerate damaged organs
using a combination of cells, biomaterials and growth factors. Mesenchymal stem cells within …

Electrochemical properties of high‐power supercapacitors using single‐walled carbon nanotube electrodes

KH An, WS Kim, YS Park, JM Moon… - Advanced functional …, 2001 - Wiley Online Library
We have investigated the key factors determining the performance of supercapacitors
constructed using single‐walled carbon nanotube (SWNT) electrodes. Several parameters, such …

[HTML][HTML] Polatuzumab vedotin in relapsed or refractory diffuse large B-cell lymphoma

…, S Assouline, TM Kim, WS Kim… - Journal of Clinical …, 2020 - ncbi.nlm.nih.gov
PURPOSE Patients with transplantation-ineligible relapsed/refractory (R/R) diffuse large B-cell
lymphoma (DLBCL) fare poorly, with limited treatment options. The antibody-drug …

Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane

Y Hao, DHK Ma, DG Hwang, WS Kim, F Zhang - Cornea, 2000 - journals.lww.com
Purpose. To identify the potential antiangiogenic and antiinflammatory proteins expressed in
human amniotic membrane tissue. Methods. Human amniotic epithelial and mesenchymal …

8 Gb 3-D DDR3 DRAM using through-silicon-via technology

…, HS Joo, WS Kim, DH Jang, NS Kim… - IEEE Journal of Solid …, 2009 - ieeexplore.ieee.org
Kim received the Grand Prize from the Samsung group for the successful development of
1 Mb and 1 Gb DRAMs in 1986 and 1996, respectively. He received several technical …

[HTML][HTML] Alpha-synuclein biology in Lewy body diseases

WS Kim, K Kågedal, GM Halliday - Alzheimer's research & therapy, 2014 - Springer
α-Synuclein is an abundantly expressed neuronal protein that is at the center of focus in
understanding a group of neurodegenerative disorders called α-synucleinopathies, which are …

The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee

…, JG Gribben, ED Hsi, BS Kahl, WS Kim… - Blood, The Journal …, 2022 - ashpublications.org
Since the publication of the Revised European-American Classification of Lymphoid Neoplasms
in 1994, subsequent updates of the classification of lymphoid neoplasms have been …

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer

…, CM Choi, SW Kim, SJ Jang, YS Park, WS Kim… - Nature …, 2012 - nature.com
Human non–small cell lung cancers (NSCLCs) with activating mutations in EGFR frequently
respond to treatment with EGFR-targeted tyrosine kinase inhibitors (TKIs), such as erlotinib, …